Related Experiment Video
Updated: Mar 31, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Melatonin for sleep problems in children with neurodevelopmental disorders
Insights
Children with neurodevelopmental disorders often experience insomnia. This review examines the off-label use of melatonin, a sleep hormone, for treating sleep issues in children with ADHD or autism spectrum disorder.
Area of Science:
- Pediatric Sleep Medicine
- Neurodevelopmental Disorders
- Pharmacology
Background:
- Children with neurodevelopmental disorders frequently suffer from sleep disturbances, including difficulty falling asleep, irregular sleep-wake cycles, and reduced sleep duration.
- These sleep problems may be linked to disruptions in the natural secretion of melatonin, a hormone crucial for regulating the sleep-wake cycle.
- Previous research reviewed melatonin use in older adults; this study focuses on pediatric populations.
Purpose of the Study:
- To review the off-label and unlicensed use of melatonin for sleep problems in children with neurodevelopmental disorders.
- To evaluate the current evidence regarding melatonin's efficacy and safety in this specific pediatric group.
Main Methods:
- Literature review of studies on melatonin use in children with attention-deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
- Analysis of data concerning sleep onset, sleep duration, and behavioral outcomes.
- Assessment of reported side effects and safety profiles.
Main Results:
- Children with ADHD and ASD exhibit high rates of insomnia and circadian rhythm disruptions.
- Melatonin is frequently used off-label to manage these sleep issues in pediatric populations.
- Evidence on efficacy and long-term safety in children with neurodevelopmental disorders is still developing.
Conclusions:
- Melatonin shows potential as a therapeutic option for sleep disturbances in children with ADHD and ASD.
- Further rigorous research is needed to establish optimal dosing, long-term efficacy, and safety.
- Clinical guidelines for melatonin use in pediatric neurodevelopmental disorders require further evidence-based development.
Abstract:
Children with neurodevelopmental disorders are at risk of sleep problems, typically difficulty getting to sleep, sleep/wake rhythm disturbances and reduced duration of sleep (insomnia). This may be associated with abnormally timed or inadequate secretion of melatonin, a naturally-occurring hormone involved in coordinating the body's sleep-wake cycle. Previously, we reviewed the use of a melatonin product licensed for primary insomnia in adults aged over 55 years. Here we review off-label and unlicensed use of melatonin in children with attention-deficit hyperactivity disorder (ADHD) or autism spectrum disorder or related neurodevelopmental disorders.
Related Concept Videos
Management of Insomnia
Nightmares and Night Terrors
Nightmares...
Narcolepsy
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...

